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Abstract 
The golden era of molecular genetic research brings about an explosion of phenotypic, 
genotypic and sequencing data.  Building on the common aims to exploit understanding 
of human diseases, it also opens up an opportunity for scientific communities to share and 
combine research data. Genome-wide association studies (GWAS) have been widely used 
to locate genetic variants, which are susceptible for common diseases. In the field of 
medical genetics, many international collaborative consortiums have been established to 
conduct meta-analyses of GWAS results and to combine large genotypic data sets to 
perform mega genetic analyses.  Having an integrated phenotype database is significant 
for exploiting the full potential of extensive genotypic data. In this paper, we aim to share 
our experience gained from integrating four heterogeneous sets of major depression 
phenotypic data onto the MySQL platform.  These data sets constitute clinical data which 
had been gathered for various genetic studies for the past decade. We also highlight in 
this report some generic data handling techniques, the costs and benefits regarding the use 
of integrated phenotype database within our own institution and under the consortium 
framework. 
1 SUMMARY 
As with other human diseases, phenotypic data for psychiatric disorders has been collected for 
a wide range of clinical and genetic studies across different research centres. Demographic 
and clinical data sets, either unstructured, semi-structured or structured, are often scattered 
and held on different systems. Our Unipolar Depression GWAS project genotyped ~3100 
cases and ~1700 controls from the samples of three previously conducted studies of recurrent 
depression and a pharmacogenetic study of antidepressant response. Phenotypic data were 
used in concert with genotypic data for the core association analyses and as covariates for 
secondary analyses to identify genetic variants that confer susceptibility to depression.  
Harmonised genetic and integrative phenotypic data are important to ensure powerful and 
reliable statistical analyses of local studies, and for participating in collaborative meta-
analyses of major depressive disorder (MDD) through the Psychiatric GWAS Consortium 
(PGC).  Building an integrated database for depression phenotype data was an integral part of 
our MDD GWAS project. Not only allows efficient retrieval of demographic and clinical 
data, it also provided us with an opportunity to reconcile scattered heterogeneous data sets 
from different restospective studies for depression.  Taking into consideration of data sharing 
and strategic bioinformatic analytics, the integrated MDD phenotype database was designed 
with flexibility for easy incorporation of new phenotypic data sets and fitting in with other 
knowledge base system. 
We completed the building of the MDD database on MySQL at the time of this report.  It has 
been fully operational and used as an invaluable resource for both our MDD GWAS and 
many other local psychiatric research projects (e.g. anxiety, suicidal behaviour, depression 
linkage follow-up study with more stringent affection status, identifying novel subtypes of 
depression, comorbidity with BMI and T2D metabolic syndrome study, etc.). Without the 
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integrated MDD phenotype database, investigators have to mess around with a bunch of 
Excel, Stata and SPSS files to pull the data together each time they conduct a new study on 
these data sets. 
One of the aims of this report is to give an account of how we structured and integrated the 
four highly heterogeneous phenotypic data sets, the issues arising from the process of 
integration from Excel, SPSS and STATA onto MySQL. A discussion on how to meet key 
requirements of data such as de-identification of subjects and data harmonisation is also 
included. There are many ways to implement a database project, the purpose of this report is 
mainly to share our experience with those bioinformaticians who are about to embark on 
similar data integration projects. 
2 INTRODUCTION 
The golden era of genetic research results in a big bang of biological and genotypic data.  
Although it might not have been obvious from the outset, managing vast amounts of 
biological, genotypic and phenotypic data has become an integral part of most modern day 
genetic research projects. Genotypic data is comparatively standard in format and structure.  
Phenotypic data on the other hand may vary greatly in content, structure and degree of data 
quality. With regard to clinical studies, many psychiatric research projects started many years 
ago. Longitudinal clinical data collections have been ongoing. Phenotypic data were 
commonly held in flat files, semi-structured SPSS, STATA or Excel spreadsheets, or simply 
put together in some Microsoft
©
 Access tables.  Proactive data quality measures were often 
neglected in these systems. 
Large sample size provides greater statistical power for GWAS. In order to secure a large 
number of subjects for the study, investigators often need to combine samples from previous 
clinical research studies. Stepping up the scale, collaborative efforts aiming to investigate the 
genetic basis of different human diseases are gathered through establishment of international 
consortiums for GWAS. Genetic projects under these settings expect shared data, both 
genotypic and phenotypic, to be harmonised, held and readily accessible in a controlled 
manner. 
At the Institute of Psychiatry, the unipolar depression GWAS (Lewis CM et al. 2010) was 
designed to draw case and control data from three retrospective studies of recurrent 
depression and a pharmacogenetic study of antidepressant response. The three depression 
studies varied considerably in study design, a more detailed description is given in the 
METHOD section. Our unipolar depression GWAS is one of PGC’s contributing studies for 
MDD.  The PGC (https://pgc.unc.edu/) was set up to conduct meta-analyses of GWAS data 
on five major psychiatric disorders: autism, attention-deficit hyperactivity disorder, bipolar 
disorder, MDD and schizophrenia. With the involvement of over 80,000 subjects (each has 
over 500,000 genotyped SNPs) and 40 billion total genotypes, these GWASs constitute the 
largest genetic research ever conducted in psychiatry. By mapping the PGC’s global aims to 
our local phenotypic data requirements, it implies that: (i) we have to assure that our studies 
use comparable diagnostic constructs, (ii) our integrated database is able to provide 
phenotypic data recorded on each subject for those data items that are required for the PGC 
GWAS analyses, and (iii) all phenotypic data have to be de-identified to ensure source 
transparency. 
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3 METHODS / APPROACH 
3.1 Data from four depression studies 
The first depression phenotypic data set (S1:DeCC/BaCC) was sourced from the Depression 
Case and Control study. Its data collected from three UK centres: London, Cardiff and 
Birmingham were held in one flat SPSS file. The second depression data set (S2:DeNt) was 
originated from the Depression Network study which was based on a family linkage study 
design (Farmer A et al. 2004). In S2, data on both probands and affected sibling pairs were 
collected by seven European sites: Aarhus in Denmark, Bonn in Germany, Dublin in Ireland, 
Lausanne in Switzerland, London; Cardiff and Birmingham in the United Kingdom, and St. 
Louis in the United States. The source of the third depression data set (S3:GCC) was a 
depression case and control study with its data collected from two European sites: Bonn in 
Germany and Lausanne in Switzerland. The phenotypic data of S2 and S3 were semi-
structured in Excel files. The fourth data set (S4:GENDEP) belongs to the the Genome-based 
Therapeutic Drugs for Depression research project (Aitchison KJ et al. 2005). S4 included 
case subjects who have been investigated for response to treatment with two particular 
antidepressants. Its data were collected from London and eight other European sites: Aarhus 
in Denmark, Brescia in Italy, Brussels in Belgium, Ljubjana in Slovenia, Mannheim and Bonn 
in Germany, Poznan in Poland and Zagreb in Croatia. Unlike the other three studies, the S4 
data were overly normalised and held as a relational database in MySQL. However, we found 
it difficult to dissect the entities with the lack of documentation on its original schema design.  
Given as an alternative, we were offered a subset of this data in STATA files which provided 
a clearer picture on the major entities and attributes. 
3.2 Road map for the design phase 
A road-map of our design and implementation approach is given in Figure 1. 
3.2.1 Conceptual modelling phase 
We began the MDD phenotype database project with a conceptual analysis. This was 
accomplished with the expertise knowledge input from our consultant psychiatrists and 
researchers in the Institute of Psychiatry. A high level conceptual model was drawn to reflect 
the concept of the subject area and to identify the major entities. We used the conceptual 
model to define the scope of the integrated MDD phenotype database. 
Common across all source studies that provided data for the database, personal demographic 
data were collected for both case and control individuals. All depression cases had been 
interviewed using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (Wing 
JK et al. 1998) focusing on their worst and second worst episodes of depression in the 
recurrent depression studies, except for S4 which included the current episode of depression 
only. A variety of other phenotypic measures relating to personality and psycho-social events, 
together with family medical history were collected under interview or self-report setting. 
3.2.2 Logical modelling phase 
Based on the conceptual model (Figure 2), we then examined each source data set in turn.  
We assessed study specific information on data items (e.g. format, domain), local entity keys, 
data labels, coding schemes for data values; how missing data and unknowns were handled; 
and how close each data set overlapped with the defined scope of the integrated MDD 
phenotype database. We conducted a data item mapping exercise to establish what attributes 
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were available at source for each major entity in the conceptual model. The data mapping 
process also generated an account of various identifiers used in the source data sets, and a 
range of coding schemes that we should be aware of when we got to the stage of data 
harmonisation. The deliverable of this stage was a logical database schema in the form of 
entity-relationship diagram (ERD). The ERD defined the key and non-key attributes for each 
identified entity and how the entities were connected to each other via defined relationships.  
We applied a directory framework to de-identify subject details. This approach requires a new 
entity to hold all local identifiers and to assign a system generated surrogate key to uniquely 
identify each subject within the integrated MDD phenotype database. Within the integrated 
database, phenotypic data on each subject are only linked by the surrogate key (subject_gid).  
External projects that require de-identified information will only be given the subject_gid to 
identify individual subject. The local identifiers are reserved specifically for facilitating data 
population and data change management. 
3.2.3 Physical modelling phase 
We chose MySQL to be our database management system. MySQL is commonly used for 
many well known bioinformatic databases, for instance, Ensembl as a joint project of the 
European Bioinformatics Institute and the Sanger Centre developed their public database 
servers using MySQL (Birney E et al. 2004), the UCSC Genome Browser set up a MySQL 
database for public access at "genome-mysql.cse.ucsc.edu" as an alternative to using the table 
browser interface (Hinrichs AS et al. 2006). Many other good reasons for the popularity of 
MySQL are listed at the MySQL website (http://www.mysql.com/why-mysql). After the 
logical database design, we proceeded to produce the physical database schema which was 
specific for the MySQL platform. We mapped entities to database tables and attributes to 
table columns. All database objects were defined using data definition SQL scripts.  Key 
attributes were translated into primary keys. We modelled the relationships using foreign key 
constraints for referential integrity, and created indexes for efficient cross table joins and fast 
data retrieval. 
3.3 Physical implementation 
3.3.1 Data migration 
Due to the heterogeneity of our source data sets, we used a staging databasing strategy for 
data migration. Each source dataset was migrated from either SPSS or STATA or Excel into 
individual MySQL staging database. The SPSS file sourced from the S1 study holds a data set 
with a dimension of 10,809 variables x 5,587 instances. We had to partition the variables and 
exported them into manageable chunks. For the STATA files from the S4 study, complication 
arised from fields of date type for which we had to reformat before the data migration. Using 
the staging databases as intermediate data store made it easier for data mapping, data 
transformation and data cleansing because both the staging databases and the integrated 
phenotype database were held on the same development platform. Elementary data cleansing, 
mostly detecting and remediating syntactical errors (e.g. typographical errors,  invalid dates, 
misplaced columns, etc.), was carried out within each staging database to ensure data quality 
was acceptable before the data were integrated. 
3.3.2 Data mapping and data population 
Before loading the phenotype data into the integrated database, we had to set up the subject 
directory. This was to ensure each subject from the source data sets would have a unique 
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surrogate identifier. This was accomplished by defining a global subject identifier in the 
subject_directory table as "INT UNSIGNED AUTO_INCREMENT PRIMARY KEY". The 
subject_directory table was designed to hold all local identifiers used at source. Upon the 
INSERT of a subject instance into the subject_directory table, MySQL would automatically 
generate a unique identification number (subject_gid) to the new row, and the local 
identifier(s) that belonged to the subject would also be stored simultaneously. Within the 
integrated MDD phenotype database, all phenotypic information related to the new subject 
would only be linked using the subject_gid. 
A second wave of data cleansing and missing data recovery were undertaken after the data 
integration. This time the data cleansing was focused on: (1) consolidating the clinical 
diagnostic codes and making sure that they conform to the standard format as stated in the 
ICD-10-DCR (International Classification of Diseases 10th edition, Diagnostic Criteria for 
Research) and DSM-IV (Diagnostic and Statistical Manual 4th edition operational criteria) 
manuals. And (2) remediating semantic data errors which could be validated against 
elementary data item(s) (e.g. age at interview was checked against date of birth and interview 
date). During the data integration process, we discovered some case subjects had no SCAN 
data. After we contacted the source data owner, these missing SCAN data were later 
recovered from a set of Access databases. 
3.3.3 Data harmonisation 
Harmonised data on attribute level facilitate data management and knowledge mining.  
Taking the data item of affection status as an instance, it was inconsistently coded across 
studies (e.g. S1 used '0' for unaffected, '1' for affected and blank for unknown status. S2 used 
'0' for unknown status, '1' for unaffected and '2' for 'affected'. S3 used 'CASE' for affected 
status whilst all subjects in S4 were set to default as 'case'). We found several other important 
attributes (e.g. gender, diagnosis codes) that lacked a harmonious uniformity. To resolve 
inconsistent data coding schemes, we applied MySQL user defined data type (i.e. ENUM) for 
data item definitions wherever necessary and appropriate. Basically, an "ENUM" type in 
MySQL is a string object with a value chosen from a list of allowed values defined by the 
user. These allowed values are enumerated explicitly in the column specification at table 
creation time. For example, we defined 'affection_status' as ENUM('affected', 'unaffected', 
'unknown') in the subject demographic details table. During data loading from the staging 
database to the integrated database, we manipulated the mapping and transformed the source 
data using the "CASE WHEN" clause in the INSERT/SELECT statement, for example:  
 
INSERT INTO integratedDB.subj_demographic_det 
(subject_gid, affection_status, ...) 
SELECT dir.subject_gid,  
CASE s2.aff_status WHEN 0 THEN 'unknown'  
WHEN 1 THEN 'unaffected'  
WHEN 2 THEN 'affected'  
END AS 'affection_status',  
... 
FROM stagingDBs2.demographic_tbl s2, integratedDB.subject_directory dir  
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WHERE s2.patient_id = dir.patient_id; 
3.3.4 Meta data 
We used meta-data to provide additional information about data labels. In the integrated 
MDD phenotype database, all SCAN data items and phenotypic measures obtained from 
various interviewing instruments are referred to by column names (e.g. s01_002 for 
questionnaire item #002 in SCAN section 1). Although we could use "COMMENT" in the 
table definitions, the details documented therein would not be accessible to the data users. The 
meta-data tables were designed to provide a catalogue of descriptions for all interview and 
self-reported questionnaire items. Clinical diagnoses for case subjects are held as codes 
compliant to the valid lists published in the ICD-10-DCR and DSM-IV manuals. Similarly, 
we set up a meta-data table to improve information content so that the users can look up what 
each abbreviated diagnostic code stands for. The meta-data have added value to the integrated 
MDD phenotype database as none existed before in any of our source data sets. 
3.3.5 Data administration 
For housekeeping purpose, each record in the integrated MDD phenotype database has a date-
stamp to keep track of last updated date.  For development control and change management 
purposes, we also keep a mirror copy of the operational database as a test bed for testing 
changes propagated from the source studies. Regular backup of the operational database is 
carried out by the I.T. support in the institute. 
4 RESULTS 
We have designed and developed an operational database for the integrated phenotypic data 
for depression. Not only have we integrated the scattered heterogenous source data sets, we 
also improved the data quality and added value to the depression phenotypic data. The 
integrated MDD phenotype database contains 20 tables and holds phenotypic data for over 
8,500 subjects. The data have been harmonised to support the GWAS project for unipolar 
depression. The integrated MDD phenotype database also meets the phenotypic data 
requirements set out by the PGC for collaborative GWAS meta-analyses. Before we 
integrated the data, the source data sets were scattered at different physical locations.  
Unknown to most investigators were the data content and data coverage in each data set, and 
most significantly the hidden parameter of data quality. Furthermore, most of the depression 
data were not readily accessible as most scientists are not equipped with I.T. skills to access 
and merge those disparate data sets from SPSS, Excel, Stata, Access and MySQL. The 
integrated MDD phenotype database has resolved most of these significant concerns. Its clean 
data have provided greater power to statistical analyses and increased reliability to scientific 
hypotheses being tested. 
5 DISCUSSION 
This database build project has highlighted the need and benefits for integrating scattered 
phenotypic data sets. Many factors, such as uncertainty regarding data contents and data 
quality, arising from the heterogeneous source data sets have made it difficult to consider 
using any of the existing data migration tools or advanced data integration techniques. 
Handling a flat SPSS file with over ten thousands variables was a great challenge. The data 
integration was further complicated by differential data handling practices at source. For 
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instance, some semantically consistent entity properties were represented differently by 
various number of elementary data items. Using multiple subject identifiers within study was 
common in most source data sets. Nonetheless, the directory approach for de-identifying 
subjects has proved to be a workable solution. The integration process enabled us to 
harmonise a large amount of phenotypic data, this certainly influences the ease of data 
mining. Having combined the phenotypic data into one integrated database on MySQL, we 
are able to gather and supply consistent harmonised data to support various research projects 
for depression or on related endo-phenotypes. This was difficult before the integrated MDD 
phenotype database was built when researchers had to delve into individual data sets and not 
knowing what data was available and how to put the data together from heterogeneous 
systems. The endophenotypes concept has been commonly used to dissect genetics of 
neuropsychiatric disorders (Gottesman I et al. 2003, Braff DL et al. 2007). Endophenotypes 
and co-morbidity studies enable classifications by decomposing complex psychiatric disorder 
diagnoses. There were successful stories about genetic analyses finding endophenotypes 
meeting association with a candidate gene or genetic loci rather than with the disease syndrom 
itself. So far, our integrated MDD phenotype database has supported several projects that go 
down this route. 
In the psychiatric research community, we have the growing need to cross search and derive 
new reliable scientific conclusions from exploring a spectrum of exisitng information 
resources (e.g. phenotypic and genotypic data, all the ~omics data etc.). It is desirable to have 
a unified data management infrastructure which is capable to automate linking and aid 
analysing data hosted by independent sources. If building the integrated MDD phenotype 
database was part of a substantial bioinformatics project, we would definitely consider more 
advanced data integration techniques such as intelligent data fusion techniques using resouce 
description framework, or semantic data interlinking using ontology-based matching and 
merging (Lopez X et al. 2007). However, this is far beyond the scope and limited by the 
resource constraint of the current MDD GWAS master project. 
We chose not to over model the schema because that would incur excess cost for 
denormalisation. More importantly our model was aimed for scalability. Using the current 
integrated schema as the reference model, any new depression phenotype data set can easily 
be mapped and merged, or interlinked as an extension to the core database. Our semi-
normalised schema design also benefits for developing biomart.  BioMart is an open source 
data management system (www.biomart.org) which has evolved to be a generic data 
integration solution and comes with a range of query interfaces (Smedley D et al. 2009). 
Institutions can develop and implement their own BioMart system for domain specific 
querying their own data sources, and at the same time accessing a range of external biomarts 
using the BioMart central portal architecture (Haider S et al. 2009). The design of our current 
integrated MDD phenotype database model can easily be modified and made compliant with 
the reversed star model as specified by BioMart. Adoption of Biomart seems to be the next 
appropriate step if we want to build a one-stop-shop for integrated resources, which would aid 
knowledge mining and help further complex analyses in psychiatric disorder research. 
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Figure 1:  The left-hand side shows the process for top-down design path.  The right-hand side 
shows our current approach, a reverse engineering path as we were committed to use existing 
data sets rather than populating the database using a pre-designed user interface with data 
validation procedures incorporated. 
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Figure 2: Boxes with solid border represent major entities or key attributes.  Lines represent 
links between entities: optional link with a circle on the line, line with an arc means exclusive-or.  
Boxes with dash-line border are added concepts for the integrative phenotype database. 
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